Resmed (RMD) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to $392.6 million.
- Resmed's Income towards Parent Company rose 1391.99% to $392.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.5 billion, marking a year-over-year increase of 1899.33%. This contributed to the annual value of $1.4 billion for FY2025, which is 3719.79% up from last year.
- According to the latest figures from Q4 2025, Resmed's Income towards Parent Company is $392.6 million, which was up 1391.99% from $348.5 million recorded in Q3 2025.
- Resmed's 5-year Income towards Parent Company high stood at $392.6 million for Q4 2025, and its period low was -$78.5 million during Q1 2021.
- Its 5-year average for Income towards Parent Company is $247.8 million, with a median of $227.3 million in 2022.
- As far as peak fluctuations go, Resmed's Income towards Parent Company plummeted by 14810.74% in 2021, and later skyrocketed by 32809.6% in 2022.
- Quarter analysis of 5 years shows Resmed's Income towards Parent Company stood at $201.8 million in 2021, then increased by 11.48% to $224.9 million in 2022, then decreased by 7.16% to $208.8 million in 2023, then soared by 65.05% to $344.6 million in 2024, then rose by 13.92% to $392.6 million in 2025.
- Its Income towards Parent Company stands at $392.6 million for Q4 2025, versus $348.5 million for Q3 2025 and $379.7 million for Q2 2025.